Phreesia, Inc. (NYSE:PHR) Stock Has Consensus Price Target of $14.07 According to Analysts

Phreesia, Inc. (NYSE:PHR) has earned an average rating of “Hold” from the nineteen analysts that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eight have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $14.07.

PHR has been the topic of several research reports. Needham & Company LLC restated a “buy” rating and set a $14.00 price objective on shares of Phreesia in a research note on Monday, August 31st. DA Davidson decreased their target price on Phreesia from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Friday, September 4th. Citigroup reiterated a “market perform” rating on shares of Phreesia in a research report on Tuesday, October 20th. Robert W. Baird boosted their price target on Phreesia from $10.00 to $11.00 and gave the company a “neutral” rating in a report on Friday, September 4th. Finally, Weiss Ratings raised Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, October 19th.

Phreesia Trading Down 0.7%

NYSE PHR opened at $12.44 on Wednesday. Phreesia has a 12 month low of $7.77 and a 12 month high of $23.78. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.76 and a quick ratio of 1.76. The company has a market capitalization of $772.15 million, a price-to-earnings ratio of 41.77 and a beta of 0.84. The company’s fifty day moving average price is $11.05 and its two-hundred day moving average price is $10.99.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.06). The company had revenue of $129.46 million for the quarter, compared to analyst estimates of $129.06 million. Phreesia had a return on equity of 5.22% and a net margin of 2.06%. Phreesia’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.01 earnings per share. As a group, research analysts predict that Phreesia will post 0.33 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Phreesia news, General Counsel Allison C. Hoffman sold 6,662 shares of the business’s stock in a transaction on Monday, September 21st. The shares were sold at an average price of $10.08, for a total transaction of $67,152.96. Following the completion of the sale, the general counsel owned 266,574 shares in the company, valued at $2,687,065.92. The trade was a 2.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 5.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Vise Technologies Inc. bought a new position in Phreesia in the third quarter worth about $106,000. Choreo LLC purchased a new position in shares of Phreesia during the 3rd quarter valued at $105,000. Sterling Capital Management LLC increased its stake in shares of Phreesia by 4.7% in the third quarter. Sterling Capital Management LLC now owns 26,410 shares of the company’s stock worth $273,000 after acquiring an additional 1,190 shares during the last quarter. State of Alaska Department of Revenue increased its stake in shares of Phreesia by 553.9% in the third quarter. State of Alaska Department of Revenue now owns 23,135 shares of the company’s stock worth $238,000 after acquiring an additional 19,597 shares during the last quarter. Finally, N10 Wealth LLC acquired a new position in shares of Phreesia in the third quarter worth $118,000. 92.10% of the stock is owned by institutional investors and hedge funds.

About Phreesia

Phreesia, Inc is a healthcare technology company that provides a platform for managing administrative and financial interactions between healthcare organizations and their patients. Its software is designed to help medical practices and other care providers streamline registration, intake, payments, communications and related workflows.

The Phreesia platform includes digital patient check-in tools that allow patients to complete forms, update demographic and insurance information, make payments and review relevant educational or administrative content.